Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear receptor-binding protein 1 (NRBP1) is a pseudokinase and adaptor protein that plays diverse roles in cellular biology[3][1]. It is implicated in embryonic development, subcellular trafficking (especially ER-to-Golgi transport), and regulation of cell fate and proliferation, notably in the intestinal epithelium[1]. In cancer biology, its function is context-dependent: NRBP1 acts as a scaffold for the P-Rex1/Rac1/Cdc42 signaling axis, promoting migration, invasion, and proliferation in triple-negative breast cancer cells, and may serve as a context-specific tumor suppressor or oncogene[2][3]. NRBP1 also participates in proteasome-mediated protein degradation, acting as a substrate recognition factor in certain E3 ubiquitin ligase complexes[4][3]. Interactions with viral proteins (e.g., Dengue NS3) suggest roles in host-pathogen interactions, potentially altering intracellular membrane architecture to facilitate viral replication[1]. Although important for several cellular functions and cancer pathways, NRBP1 is not currently an established therapeutic drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear receptor-binding protein 1 (NRBP1).